-
Signature
-
/s/ Trieu, Vuong
-
Issuer symbol
-
OTLC
-
Transactions as of
-
08 Jul 2025
-
Transactions value $
-
$994
-
Form type
-
4
-
Filing time
-
10 Jul 2025, 17:15:14 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Trieu Vuong |
CHAIRMAN AND CEO, Director, 10%+ Owner |
29397 AGOURA RD SUITE 107, AGOURA HILLS |
/s/ Trieu, Vuong |
10 Jul 2025 |
0001587074 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
OTLC |
Common Stock |
Purchase |
$520 |
+104K |
+0.11% |
$0.01 |
93.3M |
10 Jul 2025 |
Direct |
|
| transaction |
OTLC |
Common Stock |
Purchase |
$0.01 |
+1 |
+0% |
$0.01 |
93.3M |
09 Jul 2025 |
Direct |
|
| transaction |
OTLC |
Common Stock |
Purchase |
$474 |
+94.7K |
+0.1% |
$0.01 |
93.4M |
08 Jul 2025 |
Direct |
|
| holding |
OTLC |
Common Stock |
|
|
|
|
|
16.8M |
08 Jul 2025 |
By Autotelic, Inc. |
|
| holding |
OTLC |
Common Stock |
|
|
|
|
|
6.87M |
08 Jul 2025 |
By Spouse |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Remarks:
Between July 8, 2025 and July 10, 2025, Dr. Trieu purchased 198,937 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.05.